These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10651386)

  • 21. Current management strategies for intraocular retinoblastoma.
    Kim JW; Abramson DH; Dunkel IJ
    Drugs; 2007; 67(15):2173-85. PubMed ID: 17927283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
    Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoblastoma in Turkey--treatment and prognosis.
    Günalp I; Gündüz K; Arslan Y
    Jpn J Ophthalmol; 1996; 40(1):95-102. PubMed ID: 8739506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Options for Retinoblastoma.
    Mendoza PR; Grossniklaus HE
    Cancer Control; 2016 Apr; 23(2):99-109. PubMed ID: 27218786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
    Gallie BL; Budning A; DeBoer G; Thiessen JJ; Koren G; Verjee Z; Ling V; Chan HS
    Arch Ophthalmol; 1996 Nov; 114(11):1321-8. PubMed ID: 8906022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy in Retinoblastoma: Current Approaches.
    Yanık Ö; Gündüz K; Yavuz K; Taçyıldız N; Ünal E
    Turk J Ophthalmol; 2015 Dec; 45(6):259-267. PubMed ID: 27800245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservative treatment modalities in retinoblastoma.
    Chawla B; Jain A; Azad R
    Indian J Ophthalmol; 2013 Sep; 61(9):479-85. PubMed ID: 24104705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.
    Friedman DL; Krailo M; Villaluna D; Gombos D; Langholz B; Jubran R; Shields C; Murphree L; O'Brien J; Kessel S; Rodriguez-Galindo C; Chintagumpala M; Meadows AT
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28019092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
    Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
    Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
    Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES].
    Frenkel S; Weintraub M; Rot I; Shoshani N; Pe'er J
    Harefuah; 2018 Mar; 157(3):149-153. PubMed ID: 29582943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Choroidal melanoma: current therapeutic approaches].
    De Potter P
    J Fr Ophtalmol; 2002 Feb; 25(2):203-11. PubMed ID: 11941244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.